Anzhi Wei

Title: Anzhi Wei: Innovator in Therapeutic Proteins

Introduction

Anzhi Wei is a notable inventor based in Newtown, PA, who has made significant contributions to the field of therapeutic proteins. With a focus on autoimmune diseases, her work has the potential to impact many lives positively.

Latest Patents

Anzhi Wei holds a patent for "Fibronectin based scaffold domain proteins that bind IL-23." This innovative invention relates to fibronectin-based scaffold domain proteins that specifically bind interleukin 23 (IL-23). The patent also covers the use of these proteins in therapeutic applications aimed at treating autoimmune diseases. Furthermore, it includes cells that comprise such proteins, polynucleotides encoding these proteins or fragments thereof, and vectors that contain the polynucleotides.

Career Highlights

Anzhi Wei is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on addressing critical health challenges.

Collaborations

Anzhi collaborates with talented colleagues, including Ruchira Dasgupta and Steven Sheriff, who contribute to her research endeavors and help drive forward the development of new therapeutic solutions.

Conclusion

Anzhi Wei's contributions to the field of therapeutic proteins, particularly through her patent on fibronectin-based scaffold domain proteins, highlight her role as an innovator in addressing autoimmune diseases. Her work at Bristol-Myers Squibb Company and collaborations with esteemed colleagues further underscore her impact in the scientific community.